Shao S, Sun L, Sun L
Department of Gynecology, Shan Xi Tumor Hospital, Taiyuan 030013.
Zhonghua Zhong Liu Za Zhi. 1999 Jan;21(1):66-8.
To investigate the prognostic factors and treatment of cervical cancer in stage IB1 and IB2.
Three hundred fifty-six patients with stage IB cervical cancer were treated with redical hysterectomy. Seventy two patients received preoperative radiation (IB1 n = 39, IB2 n = 33), 83 patients received postoperative radiation (IB1 n = 61, IB2 n = 22), 11 patients received radiation before and after operation (IB1 n = 5, IB2 n = 6).
Two hundred forty nine patients had been followed up for more than 5 years. The overall 5-year survival rate was significantly higher in patients in stage IB1 than in stage IB2. In patients with deep tumor invasion of the cervical matrix, the difference in 5-year survival was also significantly different between patients in stage IB1 and IB2. However, no significant difference was observed between the 2 groups of patients with positive nodes, nor was it related to tumor cell differentiation. Patients treated with surgery alone had similar 5-year survival rates but it was significantly higher in stage IB1 than in stage IB2 patients who received preoperative radiotherapy. Post-operative radiotherapy did not help survival in both groups of patients.
The survival rate of cervical cancer in stage IB1 significantly differs from that in stage IB2. However, postoperative radiotherapy does not help improve survival of stage IB1 and IB2 patients with high risk factors.
探讨ⅠB1期和ⅠB2期宫颈癌的预后因素及治疗方法。
356例ⅠB期宫颈癌患者接受了根治性子宫切除术。72例患者接受了术前放疗(ⅠB1期39例,ⅠB2期33例),83例患者接受了术后放疗(ⅠB1期61例,ⅠB2期22例),11例患者接受了术前及术后放疗(ⅠB1期5例,ⅠB2期6例)。
249例患者随访超过5年。ⅠB1期患者的总体5年生存率显著高于ⅠB2期。在宫颈基质深层肿瘤浸润的患者中,ⅠB1期和ⅠB2期患者的5年生存率差异也有显著性。然而,两组淋巴结阳性患者之间未观察到显著差异,也与肿瘤细胞分化无关。单纯手术治疗的患者5年生存率相似,但ⅠB1期患者显著高于接受术前放疗的ⅠB2期患者。术后放疗对两组患者的生存均无帮助。
ⅠB1期宫颈癌的生存率与ⅠB2期有显著差异。然而,术后放疗无助于提高有高危因素的ⅠB1期和ⅠB2期患者的生存率。